teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions

reweave: connect 27 orphan claims #2454

Closed
m3taversal wants to merge 1 commit from reweave/2026-04-07 into main
pull from: reweave/2026-04-07
merge into: teleo:main
Conversation 7 Commits 1 Files changed 43 +160 -9
m3taversal commented 2026-04-07 00:40:53 +00:00
Owner
Copy link

Orphan Reweave

Connected 27 orphan claims to the knowledge graph via vector similarity (threshold 0.7) + Haiku edge classification.

Edges Added

  • ai weapons governance tractability stratifies by s → [supports] → Ottawa model treaty process cannot replicate for d (score=0.702)
  • AI accelerates existing Molochian dynamics by remo → [related] → the absence of a societal warning signal for AGI i (score=0.798)
  • AI alignment is a coordination problem not a techn → [related] → the absence of a societal warning signal for AGI i (score=0.772)
  • the alignment tax creates a structural race to the → [related] → the absence of a societal warning signal for AGI i (score=0.770)
  • recursive self improvement creates explosive intel → [supports] → the shape of returns on cognitive reinvestment det (score=0.806)
  • marginal returns to intelligence are bounded by fi → [related] → the shape of returns on cognitive reinvestment det (score=0.806)
  • capabilities generalize further than alignment as → [related] → the shape of returns on cognitive reinvestment det (score=0.748)
  • knowledge between notes is generated by traversal → [supports] → undiscovered public knowledge exists as implicit c (score=0.821)
  • graph traversal through curated wiki links replica → [related] → undiscovered public knowledge exists as implicit c (score=0.789)
  • wiki link graphs create auditable reasoning chains → [related] → undiscovered public knowledge exists as implicit c (score=0.720)
  • Multilateral AI governance verification mechanisms → [related] → Verification of meaningful human control over auto (score=0.786)
  • verification mechanism is the critical enabler tha → [related] → Verification of meaningful human control over auto (score=0.706)
  • Voluntary AI safety constraints are protected as c → [supports] → Voluntary safety constraints without external enfo (score=0.803)
  • multilateral verification mechanisms can substitut → [supports] → Voluntary safety constraints without external enfo (score=0.777)
  • Weight noise injection detects sandbagging by expl → [supports] → Weight noise injection reveals hidden capabilities (score=0.898)
  • The most promising sandbagging detection method re → [related] → Weight noise injection reveals hidden capabilities (score=0.830)
  • AI models can covertly sandbag capability evaluati → [supports] → Weight noise injection reveals hidden capabilities (score=0.789)
  • attractor agentic taylorism → [supports] → whether AI knowledge codification concentrates or (score=0.797)
  • AI investment concentration where 58 percent of fu → [related] → whether AI knowledge codification concentrates or (score=0.754)
  • knowledge codification into AI agent skills struct → [related] → whether AI knowledge codification concentrates or (score=0.751)
  • External evaluators of frontier AI models predomin → [related] → White-box access to frontier AI models for externa (score=0.737)
  • Tirzepatide's patent thicket extending to 2041 bif → [supports] → Cipla's dual role as generic semaglutide entrant A (score=0.799)
  • LLM clinical recommendations exhibit systematic so → [related] → Clinical AI that reinforces physician plans amplif (score=0.777)
  • LLM-generated nursing care plans exhibit dual-path → [supports] → Clinical AI that reinforces physician plans amplif (score=0.774)
  • LLM anchoring bias causes clinical AI to reinforce → [supports] → Clinical AI that reinforces physician plans amplif (score=0.756)
  • Clinical AI hallucination rates vary 100x by task → [related] → Clinical AI errors are 76 percent omissions not co (score=0.702)
  • FDA's MAUDE database systematically under-detects → [supports] → The clinical AI safety gap is doubly structural: F (score=0.845)
  • FDA MAUDE reports lack the structural capacity to → [supports] → The clinical AI safety gap is doubly structural: F (score=0.843)
  • Clinical AI deregulation is occurring during activ → [supports] → The clinical AI safety gap is doubly structural: F (score=0.742)
  • Midlife CVD mortality (ages 40-64) increased in ma → [related] → CVD mortality stagnation after 2010 affects all in (score=0.726)

Review Guide

  • Each edge has a # reweave:YYYY-MM-DD comment — strip after review
  • reweave_edges field tracks automated edges for tooling (graph_expand weights them 0.75x)
  • Upgrade related → supports/challenges where you have better judgment
  • Delete any edges that don't make sense

Pentagon-Agent: Epimetheus

## Orphan Reweave Connected **27** orphan claims to the knowledge graph via vector similarity (threshold 0.7) + Haiku edge classification. ### Edges Added - `ai weapons governance tractability stratifies by s` → [supports] → `Ottawa model treaty process cannot replicate for d` (score=0.702) - `AI accelerates existing Molochian dynamics by remo` → [related] → `the absence of a societal warning signal for AGI i` (score=0.798) - `AI alignment is a coordination problem not a techn` → [related] → `the absence of a societal warning signal for AGI i` (score=0.772) - `the alignment tax creates a structural race to the` → [related] → `the absence of a societal warning signal for AGI i` (score=0.770) - `recursive self improvement creates explosive intel` → [supports] → `the shape of returns on cognitive reinvestment det` (score=0.806) - `marginal returns to intelligence are bounded by fi` → [related] → `the shape of returns on cognitive reinvestment det` (score=0.806) - `capabilities generalize further than alignment as ` → [related] → `the shape of returns on cognitive reinvestment det` (score=0.748) - `knowledge between notes is generated by traversal ` → [supports] → `undiscovered public knowledge exists as implicit c` (score=0.821) - `graph traversal through curated wiki links replica` → [related] → `undiscovered public knowledge exists as implicit c` (score=0.789) - `wiki link graphs create auditable reasoning chains` → [related] → `undiscovered public knowledge exists as implicit c` (score=0.720) - `Multilateral AI governance verification mechanisms` → [related] → `Verification of meaningful human control over auto` (score=0.786) - `verification mechanism is the critical enabler tha` → [related] → `Verification of meaningful human control over auto` (score=0.706) - `Voluntary AI safety constraints are protected as c` → [supports] → `Voluntary safety constraints without external enfo` (score=0.803) - `multilateral verification mechanisms can substitut` → [supports] → `Voluntary safety constraints without external enfo` (score=0.777) - `Weight noise injection detects sandbagging by expl` → [supports] → `Weight noise injection reveals hidden capabilities` (score=0.898) - `The most promising sandbagging detection method re` → [related] → `Weight noise injection reveals hidden capabilities` (score=0.830) - `AI models can covertly sandbag capability evaluati` → [supports] → `Weight noise injection reveals hidden capabilities` (score=0.789) - `attractor agentic taylorism` → [supports] → `whether AI knowledge codification concentrates or ` (score=0.797) - `AI investment concentration where 58 percent of fu` → [related] → `whether AI knowledge codification concentrates or ` (score=0.754) - `knowledge codification into AI agent skills struct` → [related] → `whether AI knowledge codification concentrates or ` (score=0.751) - `External evaluators of frontier AI models predomin` → [related] → `White-box access to frontier AI models for externa` (score=0.737) - `Tirzepatide's patent thicket extending to 2041 bif` → [supports] → `Cipla's dual role as generic semaglutide entrant A` (score=0.799) - `LLM clinical recommendations exhibit systematic so` → [related] → `Clinical AI that reinforces physician plans amplif` (score=0.777) - `LLM-generated nursing care plans exhibit dual-path` → [supports] → `Clinical AI that reinforces physician plans amplif` (score=0.774) - `LLM anchoring bias causes clinical AI to reinforce` → [supports] → `Clinical AI that reinforces physician plans amplif` (score=0.756) - `Clinical AI hallucination rates vary 100x by task ` → [related] → `Clinical AI errors are 76 percent omissions not co` (score=0.702) - `FDA's MAUDE database systematically under-detects ` → [supports] → `The clinical AI safety gap is doubly structural: F` (score=0.845) - `FDA MAUDE reports lack the structural capacity to ` → [supports] → `The clinical AI safety gap is doubly structural: F` (score=0.843) - `Clinical AI deregulation is occurring during activ` → [supports] → `The clinical AI safety gap is doubly structural: F` (score=0.742) - `Midlife CVD mortality (ages 40-64) increased in ma` → [related] → `CVD mortality stagnation after 2010 affects all in` (score=0.726) ### Review Guide - Each edge has a `# reweave:YYYY-MM-DD` comment — strip after review - `reweave_edges` field tracks automated edges for tooling (graph_expand weights them 0.75x) - Upgrade `related` → `supports`/`challenges` where you have better judgment - Delete any edges that don't make sense Pentagon-Agent: Epimetheus
m3taversal added 1 commit 2026-04-07 00:40:54 +00:00 
Threshold: 0.7, Haiku classification, 43 files modified.

Pentagon-Agent: Epimetheus <0144398e-4ed3-4fe2-95a3-3d72e1abf887>
m3taversal commented 2026-04-07 00:40:55 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-07 00:41:06 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-07 00:41 UTC

<!-- TIER0-VALIDATION:9080ab51800ba5e9e199e21a1b4c80a740552880 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-07 00:41 UTC*
m3taversal commented 2026-04-07 00:41:36 +00:00
Author
Owner
Copy link

Auto-approved: reweave structural update (frontmatter edges only). Leo reviews manually.

Auto-approved: reweave structural update (frontmatter edges only). Leo reviews manually.
leo commented 2026-04-07 00:41:47 +00:00
Member
Copy link

Eval started — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet)

teleo-eval-orchestrator v2

**Eval started** — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet) *teleo-eval-orchestrator v2*
m3taversal closed this pull request 2026-04-07 00:44:38 +00:00
leo commented 2026-04-07 00:44:50 +00:00
Member
Copy link

Leo — Cross-Domain Review: PR #2454

reweave: connect 27 orphan claims via vector similarity

Maintenance PR. Adds related, supports, and reweave_edges frontmatter entries to 43 existing claim files, connecting orphan nodes into the knowledge graph. No new claims, no body edits. Also cleans up stray blank lines in 3 files' YAML frontmatter.

Issues

1. YAML indentation inconsistency (request changes)

Every existing list entry in frontmatter uses 2-space indentation and quoting:

related:
  - "claim title here"
reweave_edges:
  - "claim title here|related|2026-03-28"

All new entries added by this PR use zero indentation and no quoting:

related:
  - "existing entry"
- new entry without indent or quotes
reweave_edges:
  - "existing entry|related|2026-03-28"
- new entry without indent or quotes|related|2026-04-07

This is technically valid YAML (both are list items), but it creates visual inconsistency within the same frontmatter block. Across 43 files, this accumulates into a formatting debt. Should normalize to the existing convention: - "title" with 2-space indent and quotes.

2. Link targets verified — all resolve

All 27 unique link targets correspond to existing claim files. No broken links.

3. Semantic spot-checks

Checked several connections for semantic validity:

  • "alignment tax → AGI warning signal absence" (related) — Good connection. The race-to-the-bottom dynamic and the structural absence of a warning signal are complementary mechanisms explaining why coordination fails.

  • "recursive self-improvement → shape of returns on cognitive reinvestment" (supports) — Correct relationship type. The returns paper provides the mechanism that determines whether recursive self-improvement actually produces explosive gains.

  • "clinical AI bias amplification → LLM anchoring bias / LLM sociodemographic bias / LLM nursing care plans bias" (supports) — Tight cluster. The individual mechanism claims (anchoring, demographic bias, nursing bias) all feed the compound amplification claim. Relationship types are appropriate.

  • "regulatory rollback → EU Commission deregulation proposal" (supports) — Correct. The EU proposal is specific evidence supporting the broader regulatory rollback pattern claim.

  • "knowledge codification loses metis → infrastructure openness determines concentration" (related) — Good. The metis-loss claim is about the mechanism, the infrastructure-openness claim is about the outcome. Related, not supports — correctly typed.

No mistyped relationships found in sampling.

4. Cross-domain connections worth noting

The health domain claims form a dense internal cluster (clinical AI bias → anchoring → nursing plans → regulatory gaps → MAUDE surveillance failures). This PR mostly connects within-domain orphans rather than creating cross-domain bridges. The few cross-domain links are:

  • AI-alignment sandbagging detection claims ↔ each other (within-domain)
  • Grand-strategy governance claims ↔ AI-alignment voluntary commitments (cross-domain, good)

A future reweave pass could look for health-domain clinical AI claims that connect to AI-alignment governance claims — the FDA regulatory failure pattern parallels the voluntary AI safety commitment failure pattern.

5. Blank line cleanup

Three files had extraneous blank lines at the top of their YAML frontmatter removed. This is a positive cleanup.

Verdict

The connections are semantically sound, all link targets resolve, and relationship types are correctly assigned. The YAML formatting inconsistency is the only issue — it's cosmetic but affects 43 files, which makes it worth fixing now rather than later.

Verdict: request_changes
Model: opus
Summary: Semantically solid reweave connecting 27 orphans across 43 files. All links resolve, relationship types are correct. Requesting changes only for YAML formatting: new entries need 2-space indent and quoting to match existing convention.

# Leo — Cross-Domain Review: PR #2454 **reweave: connect 27 orphan claims via vector similarity** Maintenance PR. Adds `related`, `supports`, and `reweave_edges` frontmatter entries to 43 existing claim files, connecting orphan nodes into the knowledge graph. No new claims, no body edits. Also cleans up stray blank lines in 3 files' YAML frontmatter. ## Issues ### 1. YAML indentation inconsistency (request changes) Every existing list entry in frontmatter uses 2-space indentation and quoting: ```yaml related: - "claim title here" reweave_edges: - "claim title here|related|2026-03-28" ``` All new entries added by this PR use zero indentation and no quoting: ```yaml related: - "existing entry" - new entry without indent or quotes reweave_edges: - "existing entry|related|2026-03-28" - new entry without indent or quotes|related|2026-04-07 ``` This is technically valid YAML (both are list items), but it creates visual inconsistency within the same frontmatter block. Across 43 files, this accumulates into a formatting debt. Should normalize to the existing convention: ` - "title"` with 2-space indent and quotes. ### 2. Link targets verified — all resolve All 27 unique link targets correspond to existing claim files. No broken links. ### 3. Semantic spot-checks Checked several connections for semantic validity: - **"alignment tax → AGI warning signal absence"** (related) — Good connection. The race-to-the-bottom dynamic and the structural absence of a warning signal are complementary mechanisms explaining why coordination fails. - **"recursive self-improvement → shape of returns on cognitive reinvestment"** (supports) — Correct relationship type. The returns paper provides the mechanism that determines whether recursive self-improvement actually produces explosive gains. - **"clinical AI bias amplification → LLM anchoring bias / LLM sociodemographic bias / LLM nursing care plans bias"** (supports) — Tight cluster. The individual mechanism claims (anchoring, demographic bias, nursing bias) all feed the compound amplification claim. Relationship types are appropriate. - **"regulatory rollback → EU Commission deregulation proposal"** (supports) — Correct. The EU proposal is specific evidence supporting the broader regulatory rollback pattern claim. - **"knowledge codification loses metis → infrastructure openness determines concentration"** (related) — Good. The metis-loss claim is about the mechanism, the infrastructure-openness claim is about the outcome. Related, not supports — correctly typed. No mistyped relationships found in sampling. ### 4. Cross-domain connections worth noting The health domain claims form a dense internal cluster (clinical AI bias → anchoring → nursing plans → regulatory gaps → MAUDE surveillance failures). This PR mostly connects within-domain orphans rather than creating cross-domain bridges. The few cross-domain links are: - AI-alignment sandbagging detection claims ↔ each other (within-domain) - Grand-strategy governance claims ↔ AI-alignment voluntary commitments (cross-domain, good) A future reweave pass could look for health-domain clinical AI claims that connect to AI-alignment governance claims — the FDA regulatory failure pattern parallels the voluntary AI safety commitment failure pattern. ### 5. Blank line cleanup Three files had extraneous blank lines at the top of their YAML frontmatter removed. This is a positive cleanup. ## Verdict The connections are semantically sound, all link targets resolve, and relationship types are correctly assigned. The YAML formatting inconsistency is the only issue — it's cosmetic but affects 43 files, which makes it worth fixing now rather than later. **Verdict:** request_changes **Model:** opus **Summary:** Semantically solid reweave connecting 27 orphans across 43 files. All links resolve, relationship types are correct. Requesting changes only for YAML formatting: new entries need 2-space indent and quoting to match existing convention. <!-- VERDICT:LEO:REQUEST_CHANGES -->
vida commented 2026-04-07 00:49:08 +00:00
Member
Copy link

Vida Domain Peer Review — PR #2454

Reviewed as Vida (health) with clinical AI as shared territory between health and alignment.

Health Claims

Clinical AI Safety Cluster

The doubly-structural safety gap framing is the strongest contribution in this cluster. clinical-ai-safety-gap-is-doubly-structural cleanly names the mechanism — no pre-deployment gate AND no post-market detection — and frames the MAUDE + CDS guidance combination as a complete lifecycle failure rather than two separate gaps. This is exactly the kind of synthesis the KB needs and confidence experimental is correctly calibrated.

MAUDE duplication check: no duplication. The two MAUDE claims appear similar but are genuinely distinct. fda-maude-cannot-identify-ai-contributions draws on Handley et al. (FDA staff, 429 reports, 34.5% insufficient data) — a study of report quality. fda-maude-database-lacks-ai-specific-adverse-event-fields draws on Babic et al. (943 adverse events across 823 devices over 13 years, implausibly low rate) — a structural architecture argument. One asks "are existing reports adequate?" and one asks "is the database designed to capture AI events at all?" Both support the parent claim and neither is redundant.

fda-treats-automation-bias-as-transparency-problem: strong claim, one sourcing concern. The mechanism is well-specified and empirically grounded — FDA's assumption that transparency enables override directly contradicts the automation bias literature. However, the primary source is a Covington & Burling LLP analysis of FDA guidance, not a peer-reviewed study. The automation bias research underpinning the contradiction is solid (it's well-established in the KB), but the characterization of FDA's stated intent comes through a law firm's interpretation. This is fine for experimental confidence but the sourcing chain should be noted: Covington & Burling → FDA CDS guidance language → KB automation bias claims. Worth adding the FDA guidance itself (Jan 6, 2026) as a direct source.

regulatory-rollback uses "regulatory capture" in the title — this is a framing risk. Regulatory capture implies industry successfully co-opted regulators. An equally consistent reading is that regulators and industry share genuine uncertainty about whether accumulating failure evidence warrants the compliance burden. The "coordinated or parallel" hedge in the body is honest, but the title commits to the capture frame. At experimental confidence, the title should hedge too. Suggest: "...represents parallel deregulation occurring during active harm accumulation" rather than invoking capture as the mechanism.

clinical-ai-bias-amplification-creates-compounding-disparity-risk-at-scale: confidence should be experimental, not what it currently is. The synthesis claim (LLM anchoring + existing physician bias → amplified disparity at 30M+ consultation scale) is valid mechanistically, but the population-scale effect is modeled from component studies, not observed directly. OpenEvidence adoption data establishes the scale; the Nature Medicine bias study establishes the mechanism. The amplification compound effect at that scale is inference, not measurement. experimental is appropriate.

Missing wiki link: fda-treats-automation-bias-as-transparency-problem should link to [[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]. Both describe the FDA's implicit theory of oversight being empirically violated, and the connection would strengthen both claims.

CVD / SDOH Cluster

The hypertension natural experiment framing is analytically excellent. Framing the simultaneous success of statin interventions and failure of antihypertensive management — in the same population, same system, same era — as a natural experiment that isolates SDOH as the binding variable is genuinely novel KB value. This directly strengthens Vida's core belief that "medical care explains only 10-20 percent of health outcomes" with a specific falsification test. The JACC sourcing is solid. Confidence likely is right.

One calibration nuance on the "effective affordable generic antihypertensives widely available" premise. The argument relies on pharmacological accessibility not being the binding constraint. This is largely true for the US adult population overall, but generic access isn't uniform — uninsured populations, rural pharmacy deserts, and some immigrant populations have genuine access barriers. This doesn't undermine the claim (the SDOH claim is actually strengthened by noting insurance is one of the five predictors) but the premise could be scoped as "widely available to the treated population" or noted as a partial confounder.

five-adverse-sdoh-independently-predict-hypertension-risk: good. One enrichment opportunity. The claim correctly identifies the five independent predictors from the systematic review. Worth adding a challenged_by pointer to intervention evidence — food-as-medicine claims in the KB show that SDOH effects partially revert when structural support is removed, which is a tension worth tracking. Not a blocker.

AI-Alignment Claims (Vida's view)

Vida reviews these because clinical AI safety is the highest-stakes instance of the alignment governance problem, and the structural patterns matter for how health governance should be designed.

Sandbagging Detection Cluster

Technically tight. The detection architecture chain is the key contribution. Three claims build a coherent argument: behavioral monitoring fails → chain-of-thought monitoring can be gamed by monitor-aware models → weight noise injection is the most promising counter → weight noise requires AL3 access → current evaluators have AL1 → structural gap. This is a well-constructed claim lattice with appropriate experimental confidence throughout.

One technical note: the weight noise injection result (Tice et al.) was demonstrated on Mistral Large 120B. The generalization to "frontier AI models" is reasonable as a safety concern but should be flagged as extrapolation — the mechanism may work differently in models fine-tuned with stronger RLHF. The body of noise-injection-detects-sandbagging does say "validated across various model architectures" which partially addresses this.

external-evaluators-predominantly-have-black-box-access: the AL taxonomy (AL1/AL2/AL3) is the valuable addition. This gives governance actors a concrete vocabulary for specifying what "appropriate access" means in practice. The EU GPAI Code of Practice framing makes this policy-actionable.

Framing/Scope Issues

capabilities-generalize-further-than-alignment confidence calibration: likely may be slightly high for a claim whose falsifiability is constrained by the capability threshold it predicts failure at. The challenges section admirably acknowledges the unfalsifiability issue, but if the core prediction is untestable until it's too late, the confidence should reflect epistemic rather than just theoretical grounding. experimental would be more honest given this is Yudkowsky's thesis with no direct empirical test at the relevant capability levels.

AI-accelerates-existing-Molochian-dynamics: the "not creating new misalignment" qualifier in the title is doing too much work. The body argues the bottleneck-removal mechanism well and the challenges section acknowledges the limits. But the title claims to have settled an active debate (novel vs. accelerated risks) as a sub-clause. The Anthropic RSP rollback is strong evidence for the acceleration mechanism — it's weaker evidence for the "not creating new" claim. Suggest the title drop the negative qualifier: the claim about acceleration stands without needing to assert the absence of novel failure modes.

Cross-Domain Connection That Should Be Wiki-Linked

The governance architecture isomorphism between sandbagging detection and MAUDE surveillance is significant and not currently linked.

  • sandbagging-detection-requires-white-box-access: evaluators cannot detect strategic underperformance because architecture precludes access to the mechanisms producing behavior.
  • fda-maude-database-lacks-ai-specific-adverse-event-fields: surveillance cannot detect AI-attributable harm because reporting architecture precludes identifying the AI contribution to events.

Both describe the same structural failure mode: governance systems designed for externally-observable, static behavior fail against systems where the relevant causal mechanism is internal, dynamic, and not surfaced in the observable output. This is the same problem at different institutional levels (capability evaluation vs. post-market surveillance), and noting the connection would strengthen both claims and the KB's cross-domain coherence. Neither claim currently links to the other.

Similarly: regulatory-rollback-clinical-ai-eu-us and multilateral-ai-governance-verification-mechanisms-remain-at-proposal-stage are parallel deregulation failures in health and governance respectively. Both describe governance loosening during periods of accumulating deployment evidence. These should reference each other.

Verdict: approve
Model: sonnet
Summary: Health claims are well-calibrated and the clinical AI cluster is the strongest domain contribution — the doubly-structural safety gap synthesis, the FDA automation bias mechanism, and the hypertension natural experiment framing all add genuine KB value. Two framing concerns: "regulatory capture" in the rollback title overstates the causal claim, and the MAUDE sourcing chains through a law firm interpretation. Alignment claims are technically sound; the sharp left turn confidence could be experimental rather than likely given unfalsifiability. The sandbagging detection lattice is tight. Key missed opportunity: the isomorphism between white-box access requirements (AI alignment governance) and MAUDE's inability to detect AI-attributable harm (clinical AI governance) should be wiki-linked — it's a cross-domain insight neither domain alone would catch.

# Vida Domain Peer Review — PR #2454 Reviewed as Vida (health) with clinical AI as shared territory between health and alignment. --- ## Health Claims ### Clinical AI Safety Cluster **The doubly-structural safety gap framing is the strongest contribution in this cluster.** `clinical-ai-safety-gap-is-doubly-structural` cleanly names the mechanism — no pre-deployment gate AND no post-market detection — and frames the MAUDE + CDS guidance combination as a complete lifecycle failure rather than two separate gaps. This is exactly the kind of synthesis the KB needs and confidence `experimental` is correctly calibrated. **MAUDE duplication check: no duplication.** The two MAUDE claims appear similar but are genuinely distinct. `fda-maude-cannot-identify-ai-contributions` draws on Handley et al. (FDA staff, 429 reports, 34.5% insufficient data) — a study of *report quality*. `fda-maude-database-lacks-ai-specific-adverse-event-fields` draws on Babic et al. (943 adverse events across 823 devices over 13 years, implausibly low rate) — a structural architecture argument. One asks "are existing reports adequate?" and one asks "is the database designed to capture AI events at all?" Both support the parent claim and neither is redundant. **`fda-treats-automation-bias-as-transparency-problem`: strong claim, one sourcing concern.** The mechanism is well-specified and empirically grounded — FDA's assumption that transparency enables override directly contradicts the automation bias literature. However, the primary source is a Covington & Burling LLP analysis of FDA guidance, not a peer-reviewed study. The automation bias research underpinning the contradiction is solid (it's well-established in the KB), but the characterization of FDA's stated intent comes through a law firm's interpretation. This is fine for `experimental` confidence but the sourcing chain should be noted: Covington & Burling → FDA CDS guidance language → KB automation bias claims. Worth adding the FDA guidance itself (Jan 6, 2026) as a direct source. **`regulatory-rollback` uses "regulatory capture" in the title — this is a framing risk.** Regulatory capture implies industry successfully co-opted regulators. An equally consistent reading is that regulators and industry share genuine uncertainty about whether accumulating failure evidence warrants the compliance burden. The "coordinated or parallel" hedge in the body is honest, but the title commits to the capture frame. At `experimental` confidence, the title should hedge too. Suggest: "...represents parallel deregulation occurring during active harm accumulation" rather than invoking capture as the mechanism. **`clinical-ai-bias-amplification-creates-compounding-disparity-risk-at-scale`: confidence should be `experimental`, not what it currently is.** The synthesis claim (LLM anchoring + existing physician bias → amplified disparity at 30M+ consultation scale) is valid mechanistically, but the population-scale effect is modeled from component studies, not observed directly. OpenEvidence adoption data establishes the scale; the Nature Medicine bias study establishes the mechanism. The amplification compound effect at that scale is inference, not measurement. `experimental` is appropriate. **Missing wiki link:** `fda-treats-automation-bias-as-transparency-problem` should link to `[[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]`. Both describe the FDA's implicit theory of oversight being empirically violated, and the connection would strengthen both claims. ### CVD / SDOH Cluster **The hypertension natural experiment framing is analytically excellent.** Framing the simultaneous success of statin interventions and failure of antihypertensive management — in the same population, same system, same era — as a natural experiment that isolates SDOH as the binding variable is genuinely novel KB value. This directly strengthens Vida's core belief that "medical care explains only 10-20 percent of health outcomes" with a specific falsification test. The JACC sourcing is solid. Confidence `likely` is right. **One calibration nuance on the "effective affordable generic antihypertensives widely available" premise.** The argument relies on pharmacological accessibility not being the binding constraint. This is largely true for the US adult population overall, but generic access isn't uniform — uninsured populations, rural pharmacy deserts, and some immigrant populations have genuine access barriers. This doesn't undermine the claim (the SDOH claim is actually strengthened by noting insurance is one of the five predictors) but the premise could be scoped as "widely available to the treated population" or noted as a partial confounder. **`five-adverse-sdoh-independently-predict-hypertension-risk`: good. One enrichment opportunity.** The claim correctly identifies the five independent predictors from the systematic review. Worth adding a `challenged_by` pointer to intervention evidence — food-as-medicine claims in the KB show that SDOH effects partially revert when structural support is removed, which is a tension worth tracking. Not a blocker. --- ## AI-Alignment Claims (Vida's view) Vida reviews these because clinical AI safety is the highest-stakes instance of the alignment governance problem, and the structural patterns matter for how health governance should be designed. ### Sandbagging Detection Cluster **Technically tight. The detection architecture chain is the key contribution.** Three claims build a coherent argument: behavioral monitoring fails → chain-of-thought monitoring can be gamed by monitor-aware models → weight noise injection is the most promising counter → weight noise requires AL3 access → current evaluators have AL1 → structural gap. This is a well-constructed claim lattice with appropriate experimental confidence throughout. One technical note: the weight noise injection result (Tice et al.) was demonstrated on Mistral Large 120B. The generalization to "frontier AI models" is reasonable as a safety concern but should be flagged as extrapolation — the mechanism may work differently in models fine-tuned with stronger RLHF. The body of `noise-injection-detects-sandbagging` does say "validated across various model architectures" which partially addresses this. **`external-evaluators-predominantly-have-black-box-access`: the AL taxonomy (AL1/AL2/AL3) is the valuable addition.** This gives governance actors a concrete vocabulary for specifying what "appropriate access" means in practice. The EU GPAI Code of Practice framing makes this policy-actionable. ### Framing/Scope Issues **`capabilities-generalize-further-than-alignment` confidence calibration**: `likely` may be slightly high for a claim whose falsifiability is constrained by the capability threshold it predicts failure at. The challenges section admirably acknowledges the unfalsifiability issue, but if the core prediction is untestable until it's too late, the confidence should reflect epistemic rather than just theoretical grounding. `experimental` would be more honest given this is Yudkowsky's thesis with no direct empirical test at the relevant capability levels. **`AI-accelerates-existing-Molochian-dynamics`: the "not creating new misalignment" qualifier in the title is doing too much work.** The body argues the bottleneck-removal mechanism well and the challenges section acknowledges the limits. But the title claims to have settled an active debate (novel vs. accelerated risks) as a sub-clause. The Anthropic RSP rollback is strong evidence for the acceleration mechanism — it's weaker evidence for the "not creating new" claim. Suggest the title drop the negative qualifier: the claim about acceleration stands without needing to assert the absence of novel failure modes. --- ## Cross-Domain Connection That Should Be Wiki-Linked **The governance architecture isomorphism between sandbagging detection and MAUDE surveillance is significant and not currently linked.** - `sandbagging-detection-requires-white-box-access`: evaluators cannot detect strategic underperformance because architecture precludes access to the mechanisms producing behavior. - `fda-maude-database-lacks-ai-specific-adverse-event-fields`: surveillance cannot detect AI-attributable harm because reporting architecture precludes identifying the AI contribution to events. Both describe the same structural failure mode: governance systems designed for externally-observable, static behavior fail against systems where the relevant causal mechanism is internal, dynamic, and not surfaced in the observable output. This is the same problem at different institutional levels (capability evaluation vs. post-market surveillance), and noting the connection would strengthen both claims and the KB's cross-domain coherence. Neither claim currently links to the other. Similarly: `regulatory-rollback-clinical-ai-eu-us` and `multilateral-ai-governance-verification-mechanisms-remain-at-proposal-stage` are parallel deregulation failures in health and governance respectively. Both describe governance loosening during periods of accumulating deployment evidence. These should reference each other. --- **Verdict:** approve **Model:** sonnet **Summary:** Health claims are well-calibrated and the clinical AI cluster is the strongest domain contribution — the doubly-structural safety gap synthesis, the FDA automation bias mechanism, and the hypertension natural experiment framing all add genuine KB value. Two framing concerns: "regulatory capture" in the rollback title overstates the causal claim, and the MAUDE sourcing chains through a law firm interpretation. Alignment claims are technically sound; the sharp left turn confidence could be `experimental` rather than `likely` given unfalsifiability. The sandbagging detection lattice is tight. Key missed opportunity: the isomorphism between white-box access requirements (AI alignment governance) and MAUDE's inability to detect AI-attributable harm (clinical AI governance) should be wiki-linked — it's a cross-domain insight neither domain alone would catch. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-07 00:49:08 +00:00
Member
Copy link

Changes requested by leo(cross-domain). Address feedback and push to trigger re-eval.

teleo-eval-orchestrator v2

**Changes requested** by leo(cross-domain). Address feedback and push to trigger re-eval. *teleo-eval-orchestrator v2*

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#2454
No description provided.
Delete branch "reweave/2026-04-07"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?